Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy
Autor: | Kelly A Johnson, Hideaki Okochi, Mireya Arreguin, Joseph Watabe, David V Glidden, Anindita Chattopadhyay, Elizabeth Imbert, Matthew D Hickey, Monica Gandhi, Matthew Spinelli |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Clinical Infectious Diseases. 76:930-933 |
ISSN: | 1537-6591 1058-4838 |
DOI: | 10.1093/cid/ciac828 |
Popis: | We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59–20.14; P = .007). This suggests an existing point-of-care assay developed for tenofovir disoproxil fumarate will support adherence monitoring for patients on all TFV-based antiretrovirals. |
Databáze: | OpenAIRE |
Externí odkaz: |